SEC Form 4 · accession 0001127602-16-048818
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Kuntz
Officer — SrVP & Chief Scien, Clin, Reg
Period of report
Apr 1, 2016
Accepted (ET)
Apr 5, 2016 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Apr 1, 2016 | S | 4,000 | $75.2197 | D | 104,358 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This balance increased by 269 shares due to exempt transactions such as dividend reinvestment.
- F2The price reported in Column 4 is a weighted Average price. The shares were sold in multiple transactions at prices ranging from $75.2701 to $75.47, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.